Citation: Jy. Ranchere, CRITICAL ANALYSIS OF RECOMMENDATIONS AS REFERENTIAL MATERIAL IN THE CLINICAL PRACTICAL, Bulletin du cancer, 85(10), 1998, pp. 895-898
Authors:
RANCHERE JY
LATOUR JF
FUHRMANN C
LAGALLARDE C
LOREUIL F
Citation: Jy. Ranchere et al., AMPHOTERICIN-B INTRALIPID FORMULATION - STABILITY AND PARTICLE, Journal of antimicrobial chemotherapy, 37(6), 1996, pp. 1165-1169
Citation: Jy. Ranchere et al., POSTOPERATIVE INFECTIONS IN IMMUNOCOMPROMISED PATIENTS AFTER ONCOLOGICAL SURGERY, Supportive care in cancer, 3(6), 1995, pp. 409-413
Authors:
COTTIN V
NEGRIER S
RANCHERE JY
MERCATELLO A
MERROUCHE Y
NEGRIER C
PHILIP T
Citation: V. Cottin et al., TREATMENT OF INTERLEUKIN-2-INDUCED THROMBOCYTOPENIA BY INTRAVENOUS IMMUNOGLOBULIN, European journal of cancer, 30A(14), 1994, pp. 2187-2187
Authors:
HOEKSTRA A
BASSOT V
BERTOGLIO S
BOBIN JY
DELASSUS P
EGELI R
KHAYAT D
RANCHERE JY
SANTINI J
SEGOL P
Citation: A. Hoekstra et al., CLINICAL-EVALUATION OF THE CORDIS VASCULAR ACCESS PORT SYSTEMS - A MULTICENTER STUDY, Medical oncology and tumor pharmacotherapy, 10(3), 1993, pp. 131-138